Can a single psychedelic experience shift your entire worldview? It’s a provocative question, and one that’s sparked widespread interest as
Recent research suggests that psilocybin shows promise in treating addiction. Studies have demonstrated its potential efficacy in treating tobacco and
In our recent large-scale study of psilocybin magic mushrooms, 4.6% of users reported using psilocybin while on an antidepressant.
You can access a list of currently recruiting U.S. clinical trials on psilocybin through ClinicalTrials.gov.
Results from our recent large-scale study with John Hopkins University found significantly decreased depression persisting for months following psilocybin ingestion.
Psilocybin has been used safely for patients with OCD and was associated with acute reductions in core OCD symptoms in
From our naturalistic psilocybin study, the average initial dose of dried psilocybin mushrooms was 3.1 grams.
Data from our psilocybin study found that participants primarily used psilocybin with the intention of self-exploration, mental health, and therapy.
Psychedelic-induced visual effects can occur with eyes-open or eyes-closed, but visual alterations under classic psychedelics can include rich phenomenological accounts
Nausea is a common side effect of psilocybin ingestion. Mushrooms are largely made up of chitin, which can cause gastrointestinal
Join our email list and get immediate access to part one of our psilocybin guide. You’ll also get the latest in how we’re bridging the gap between science and soul: psychedelic research updates, real-world findings, community-driven education, personal stories and expert insights on natural medicine.
Advancing Real-World Psychedelic Research and Science-Backed Education
Unlimited Sciences is provided with a nonprofit status by fiscal sponsorship through Realm of Caring Foundation.
Federal EIN: 46-3371348.
© 2025 Unlimited Sciences. All Rights Reserved.
Designed by Gloss
